Pfizer picked up a speedy FDA nod for palbociclib, a breast cancer treatment with blockbuster potential, barreling toward the market as it works to carve out a bigger share of the oncology space.

…read more

Source: Pfizer wins early FDA approval for a potential cancer blockbuster


0 No comments